QSI - NASDAQ
Quantum-Si incorporated
$1.28
+3.2%Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.
At a Glance
Live Snapshotqsi
Common Stock
Last Annual Value
22.00K
3-Year CAGR
16%
5-Year CAGR
86%
10-Year CAGR
36%
Quantum-Si incorporated Competitors Analysis of Common Stock
| Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Quantum-Si incorporated NASDAQ:QSI | 22.00K | 16.3% | 9.5% | N/A | |
 Aura Biosciences, Inc. NASDAQ:AURA | 0.00 | N/A | N/A | N/A | |
 Corvus Pharmaceuticals, Inc. NASDAQ:CRVS | 7.00K | 11.9% | 7.0% | 13.3% | |
 Gossamer Bio, Inc. NASDAQ:GOSS | 24.00K | 1.4% | 24.6% | N/A | |
 Inhibrx Biosciences, Inc. NASDAQ:INBX | 1.00K | -41.5% | -24.2% | N/A | |
 Lexicon Pharmaceuticals, Inc. NASDAQ:LXRX | 366.00K | 14.3% | 19.5% | 13.3% | |
 Ocugen, Inc. NASDAQ:OCGN | 3.12M | 6.8% | 9.4% | 34.7% | |
 Verastem, Inc. NASDAQ:VSTM | 8.00K | 38.7% | -15.9% | 7.2% | |
 Prothena Corporation plc NASDAQ:PRTA | 538.00K | 0.1% | 2.9% | 4.5% | |
 I-Mab NASDAQ:IMAB | 19.00K | 0.4% | -31.5% | N/A | |
 Rocket Pharmaceuticals, Inc. NASDAQ:RCKT | 1.08M | 6.2% | 10.9% | 14.9% |
Quantum-Si incorporated Fair Value Envelope
Related Guides
Continue your QSI research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.